On February 21, 2024, the Board of Directors of CNS Pharmaceuticals, Inc. approved the following appointments to its Board committees: (i) Audit Committee Jeff Keyes (Chair), Carl Evans and Amy Mahery; (ii) Compensation Committee Dr. Jerzy (George) Gumulka (Chair), Jeff Keyes and Dr. Bettina Cockroft; and (iii) Nominating and Governance Committee Dr. Bettina Cockroft (Chair) and Faith Charles.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.139 USD | +6.92% | -32.70% | -89.14% |
Jun. 03 | CNS Pharmaceuticals Schedules 1-For-50 Reverse Stock Split This Week | MT |
May. 15 | CNS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- CNSP Stock
- News CNS PHARPAR
- CNS Pharmaceuticals, Inc. Approves the Appointments to its Board Committees